A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines.
about
Polymeric Nanostructures for Imaging and TherapyData Mining as a Guide for the Construction of Cross-Linked Nanoparticles with Low Immunotoxicity via Control of Polymer Chemistry and Supramolecular Assembly.Intravenous hemostats: challenges in translation to patientsEndothelial nanomedicine for the treatment of pulmonary disease.Past, Present, and Future of Lipid Resuscitation Therapy.Hypersensitivity to intravenous iron: classification, terminology, mechanisms and managementNanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.FEASIBILITY AND SAFETY OF CONTRAST-ENHANCED ULTRASOUND IN THE DISTAL LIMB OF SIX HORSES.Safety of poly (ethylene glycol)-coated perfluorodecalin-filled poly (lactide-co-glycolide) microcapsules following intravenous administration of high amounts in ratsMaterials design at the interface of nanoparticles and innate immunity.Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.Contrast-enhanced sonothrombolysis in a porcine model of acute peripheral arterial thrombosis and prevention of anaphylactic shock.Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety.Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization
P2860
Q30372383-3CF23336-C1F8-478E-AE3D-CB22450833A0Q30958719-3DE60137-A960-408C-91C2-2F2B0219F00CQ38148673-3F93800E-70F3-491B-9F62-5536833E105BQ38267984-64F8EB8E-3705-4895-9CAD-22A2C78E5F54Q38549786-D2FB858A-EFBE-4BF9-9601-F8D0D6C7124CQ38564991-2FE12550-93FD-4FF5-9722-9359F0FF1F63Q38891729-8BBD87E3-E0FE-46FC-B970-4225A55FD860Q38920962-08C09591-E7A5-4646-B955-FEF408C0A62DQ40473772-5D22AFD0-6358-4032-99AF-A524E82ADFCBQ41915826-088AB5FA-7D15-444D-9E52-86989C111F76Q42339164-69F115D5-7B69-4D44-AEAD-1E056C8D1BBCQ48029527-6C757CD8-F245-43B9-8C8A-2CACCF8CB5E5Q51752450-B93DBE11-EAB1-49E7-BC64-8EFE8FE8B0ADQ55291163-6FB7A3E7-A23B-4444-B022-CFA5FB13715BQ57815916-E449B7FC-2279-4E2F-8EB9-95947D753366
P2860
A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A porcine model of complement- ...... nosystems and other medicines.
@en
type
label
A porcine model of complement- ...... nosystems and other medicines.
@en
prefLabel
A porcine model of complement- ...... nosystems and other medicines.
@en
P2093
P1476
A porcine model of complement- ...... nosystems and other medicines.
@en
P2093
Domokos Csukás
János Szebeni
László Rosivall
Péter Bedőcs
Rolf Bünger
Rudolf Urbanics
P304
P356
10.1016/J.ADDR.2012.07.005
P407
P577
2012-07-20T00:00:00Z